Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027495 · ClinicalTrials.gov registry record · Phase 1
Curcumin for the Prevention of Colon Cancer
A Phase 1 study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00027495: Completed Phase 1 study, sponsored by University of Michigan Rogel Cancer Center.
NCT00027495 is a Phase 1 study that has completed, run by University of Michigan Rogel Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00027495, a Phase 1 study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. Curcumin may be effective in preventing the development of colon cancer. PURPOSE: Phase I trial to determine the dose amount of curcumin that can be tolerated to help in preventing colon cancer in healthy men and women.
Interventions
- DIETARY_SUPPLEMENT curcumin
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-12 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
What the finished NCT00027495 record still lists
NCT00027495 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which curcumin is the first listed.
NCT00027495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00027495 about?
NCT00027495 is a clinical study titled "Curcumin for the Prevention of Colon Cancer". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. Curcumin may be effective in preventing the development of colon cancer. PURPOSE: Phase I trial to determine the dose amount of curcumin that can be tolerated to help in preventing colon canc...
What is the current status of trial NCT00027495?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-12. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00027495?
The interventions under investigation include: curcumin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00027495?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia